Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 12678333)

1.

Defining relapse of ulcerative colitis using a symptom-based activity index.

Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR.

Scand J Gastroenterol. 2003 Feb;38(2):164-71.

PMID:
12678333
2.

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, Walters TD, Zachos M, Mamula P, Beaton DE, Steinhart AH, Griffiths AM.

Gastroenterology. 2007 Aug;133(2):423-32. Epub 2007 May 21.

PMID:
17681163
3.

Does colonoscopy cause increased ulcerative colitis symptoms?

Menees S, Higgins P, Korsnes S, Elta G.

Inflamm Bowel Dis. 2007 Jan;13(1):12-8.

PMID:
17206634
4.

The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.

Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA.

J Crohns Colitis. 2013 Dec;7(11):890-900. doi: 10.1016/j.crohns.2012.11.007. Epub 2012 Dec 24.

PMID:
23269224
5.

Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M.

Scand J Gastroenterol. 2001 Jan;36(1):77-85.

PMID:
11218243
6.

An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.

Bewtra M, Brensinger CM, Tomov VT, Hoang TB, Sokach CE, Siegel CA, Lewis JD.

Inflamm Bowel Dis. 2014 Jun;20(6):1070-8. doi: 10.1097/MIB.0000000000000053.

7.

A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.

Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1081-8. doi: 10.1016/j.cgh.2009.06.024. Epub 2009 Jul 1.

PMID:
19577010
8.

Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Ludwig D, Wiener S, Brüning A, Schwarting K, Jantschek G, Fellermann K, Stahl M, Stange EF.

Gut. 1999 Oct;45(4):546-52.

9.

Appraisal of the pediatric ulcerative colitis activity index (PUCAI).

Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, LeLeiko N, Griffiths AM; Pediatric IBD Collaborative Research Group.

Inflamm Bowel Dis. 2009 Aug;15(8):1218-23. doi: 10.1002/ibd.20867.

PMID:
19161178
10.

The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis.

Jowett SL, Seal CJ, Barton JR, Welfare MR.

Am J Gastroenterol. 2001 Oct;96(10):2921-8.

PMID:
11693327
11.

Assessing disease activity in ulcerative colitis: patients or their physicians?

Turner D, Griffiths AM, Mack D, Otley AR, Seow CH, Steinhart AH, Silverberg MS, Hyams J, Guyatt GH.

Inflamm Bowel Dis. 2010 Apr;16(4):651-6. doi: 10.1002/ibd.21088.

PMID:
19708058
12.
13.

A refined symptom-based approach to diagnose pulmonary tuberculosis in children.

Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N.

Pediatrics. 2006 Nov;118(5):e1350-9.

14.

Can calprotectin predict relapse risk in inflammatory bowel disease?

D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F, Oliva L, Sturniolo GC.

Am J Gastroenterol. 2008 Aug;103(8):2007-14.

PMID:
18802997
15.

The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.

Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN.

Am J Gastroenterol. 2009 Jul;104(7):1754-63. doi: 10.1038/ajg.2009.197. Epub 2009 May 19.

PMID:
19455122
16.

Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis.

Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, Dobos GJ.

Inflamm Bowel Dis. 2005 Dec;11(12):1085-91.

PMID:
16306771
17.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.

Am J Gastroenterol. 2009 Nov;104(11):2760-7. doi: 10.1038/ajg.2009.410. Epub 2009 Jul 21.

PMID:
19623172
18.

Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.

Herrlinger KR, Dittmann R, Weitz G, Wehkamp J, Ludwig D, Schwab M, Stange EF, Fellermann K.

Inflamm Bowel Dis. 2004 May;10(3):229-33.

PMID:
15290916
19.

A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.

Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.

Am J Gastroenterol. 2004 Jun;99(6):1122-8.

PMID:
15180735
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk